Mode
Text Size
Log in / Sign up
N/A N=74 Randomized Quadruple-blind Treatment

Antibiotic Efficacy in Pneumonitis Following Paraffin (Kerosene) Ingestion in Children

Kerosene Pneumonitis

Enrolled (actual)
74
Serious AEs
0.0%
Results posted
Jun 2013
Primary outcome: Primary: Treatment Failure — 3; 2 participants — p=>0.50

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Amoxicillin (Drug); Placebo (Drug)
Age
Pediatric · 0+ yrs
Sex
All
Sponsor
University of Cape Town
Primary completion
Sep 2011

Outcome Measures

OutcomeResultp-value
PRIMARY
Treatment Failure
3; 2 >0.50

Summary

Paraffin (kerosene) ingestion in the developing world accounts for a large number of visits to healthcare facilities, especially amongst children. There is no evidence in animals and no good evidence in humans that the use of early antibiotics improves the clinical outcome of paraffin-induced pneumonitis. This randomised placebo-controlled trial will investigate whether the use of early antibiotics affects the clinical course of children with pneumonitis following paraffin ingestion.

Eligibility Criteria

Inclusion Criteria

  • Ingestion in the preceding 24 hours
  • Presence of respiratory symptoms and/or signs at presentation
  • Informed consent obtained from parent or legal guardian
  • Resident within the Red Cross Hospital drainage area and able to come for two follow-up appointments

Exclusion Criteria

  • Asymptomatic and no clinical signs
  • Too ill to be excluded from receiving an antibiotic as judged by:
  • Requiring more than 2L/min nasal-prong oxygen
  • Requiring continuous or intermittent positive airway pressure ventilation
  • Fever > 40˚C
  • Needing an antibiotic for another reason e.g. otitis media, tonsillitis
  • Current antibiotic use, prior to kerosene ingestion
  • Allergic to amoxicillin
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01253980). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search